Company Overview
About Endogenex
Endogenex is a medical device company headquartered in New Hope, Minnesota, developing endoscopic therapies for metabolic diseases. Its flagship product, the ReCET (Re-Cellularization via Electroporation Therapy) System, uses a catheter-based approach to deliver controlled electrical pulses to the duodenal lining. This non-surgical procedure remodels the duodenal epithelium — the tissue layer believed to play a key role in insulin resistance and glucose regulation — restoring more normal metabolic signaling without removing or bypassing anatomy.
Business Model & Competitive Advantage
The company raised a $25M Series B in 2024, building on earlier capital rounds and grant funding. Endogenex has completed European clinical investigations of the ReCET System, with trial data demonstrating meaningful improvements in glycemic control — including participants achieving drug-free diabetes remission in combination with a dietary protocol. These results have driven interest from gastroenterologists and endocrinologists seeking durable, minimally invasive alternatives to GLP-1 medications and metabolic surgery (such as gastric bypass) for patients with Type 2 diabetes.
Competitive Landscape 2025–2026
Endogenex is pursuing CE Mark in Europe and working toward US FDA investigational device exemption (IDE) trials. The company's approach targets the large and growing population of Type 2 diabetes patients who are not adequately controlled on medication, not candidates for bariatric surgery, or seeking a non-pharmacological option. Endogenex competes and potentially complements therapies in the procedural metabolic disease space, positioning ReCET as an earlier-line, repeatable intervention.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Headspace
Headspace is a mental wellness company founded in 2010 by Andy Puddicombe and Rich Pierson that has grown into one of the most widely used mindfulness and meditation apps globally. The platform offers
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Noom
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to beha
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Compare Endogenex with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Endogenex? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Endogenex Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Endogenex vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →